ADVIL ALLERGY SINUS OTC
Generic Name and Formulations:
Ibuprofen 200mg, chlorpheniramine maleate 2mg, pseudoephedrine HCl 30mg; coated-caplets.
Pfizer Consumer Healthcare
Indications for ADVIL ALLERGY SINUS:
Nasal congestion, sinus pressure, rhinorrhea, headache, minor aches and pains, fever.
Take with food. 1 caplet every 4–6hrs; max 6 caplets/24hrs.
<12yrs: not recommended.
Aspirin allergy. Immediately before or after cardiac surgery. During or within 14 days of MAOIs.
Increased risk of severe stomach bleeding (esp. ≥60yrs old). History of GI disorders (eg, heartburn, bleeding ulcers). Respiratory disorders (eg, emphysema, bronchitis). Increased risk of heart attack or failure, and stroke. Hypertension. Heart disease. Recent stroke. Liver cirrhosis. Renal disease. Asthma. Thyroid disease. Diabetes. Glaucoma. GI or urinary obstruction. Reevaluate if fever persists or worsens >3 days or nasal congestion lasts >7 days. Elderly. Pregnancy (avoid during 3rd trimester). Nursing mothers.
NSAID + antihistamine + sympathomimetic.
Hypertensive crisis with MAOIs. β-blockers may increase the pressor effects of sympathomimetics. Caution with diuretics. Avoid aspirin, pseudoephedrine- or chlorpheniramine-containing products, or other pain relievers, nasal decongestants, antihistamines. Alcohol, sedatives and tranquilizers may increase drowsiness. Increased risk of GI bleed with anticoagulants, corticosteroids, other OTC or Rx NSAIDs, ≥3 alcoholic drinks/day, or prolonged use.
Drowsiness, nervousness, dizziness, insomnia, GI upset/bleed, symptoms of heart problems or stroke (eg, trouble breathing, feel faint, slurred speech), redness, swelling, allergic reactions; discontinue if occur.
Clinical Pain Advisor Articles
- Analyzing Coverage of Nonpharmacologic Treatments for Low Back Pain
- Smartphone App Helps Evaluate Catastrophizing in Chronic Pain
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Dsuvia Gains FDA Approval: We Want to Hear Your Thoughts
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Dozens of Medical Groups Join Forces to Improve Diagnoses
- FDA Grants Non-Opioid Analgesic VVZ-149 Fast Track Status
- Little to No Association Found Between Physician Performance and Medical School Ranking